AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25233652 — intervention group
Group type: EXPERIMENTAL
Intervention: Jin three-needle therapy combined with MOTOmed intelligent motor training
Number of subjects: 80
Study 25233652 — intervention group
Group type: COMPARATOR
Intervention: MOTOmed and conventional rehabilitation training (Control)
Number of subjects: 80
Study 22484337 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet coping skills training program
Number of subjects: 300
Study 22484337 — intervention group
Group type: COMPARATOR
Intervention: Internet diabetes education (control condition)
Number of subjects: 300
Study 19424890 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intensive speech and language therapy weekly over an 8-month period
Number of subjects: 24
Study 19424890 — intervention group
Group type: COMPARATOR
Intervention: Nursery-based model of intervention
Number of subjects: 24
Study 19424890 — intervention group
Group type: COMPARATOR
Intervention: No Intervention
Number of subjects: 24
Study 17622517 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 0
Study 17622517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15619563 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinospora cordifolia (TC)
Number of subjects: 75
Study 15619563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 12177654 — intervention group
Group type: EXPERIMENTAL
Intervention: Downsloping ST-segment morphology
Number of subjects: 64
Study 12177654 — intervention group
Group type: EXPERIMENTAL
Intervention: Horizontal ST-segment morphology
Number of subjects: 64
Study 12177654 — intervention group
Group type: EXPERIMENTAL
Intervention: No ischemic electrocardiographic response
Number of subjects: 64
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control using sulphonylureas or insulin therapy or metformin in overweight patients
Number of subjects: 5000
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood glucose control
Number of subjects: 5000
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control with captopril
Number of subjects: 5000
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose control
Number of subjects: 5000
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Drugs or insulin used for blood glucose control
Number of subjects: 5000
Study 10398549 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 5000
Study 7769811 — intervention group
Group type: EXPERIMENTAL
Intervention: bisoprolol (single oral dose)
Number of subjects: 12
Study 7769811 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid based feed
Number of subjects: 24
Study 1905672 — intervention group
Group type: COMPARATOR
Intervention: Whole protein feed
Number of subjects: 24
Study 1905672 — intervention group
Group type: COMPARATOR
Intervention: Whole protein feed (after crossover)
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid based feed (after crossover)
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral feeding (general)
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid food introduction
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintroduction of green vegetables
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Return to enteral feed after relapse from green vegetables
Number of subjects: 24
Study 1905672 — intervention group
Group type: EXPERIMENTAL
Intervention: Reintroduction of low residue diet after remission
Number of subjects: 24
Study 6307777 — intervention group
Group type: COMPARATOR
Intervention: Normal diet according to age
Number of subjects: 28
Study 6307777 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ml of fresh human milk per day
Number of subjects: 28
Study 30312214 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (OSAT group, n = 20)
Number of subjects: 41
Study 30312214 — intervention group
Group type: COMPARATOR
Intervention: Nontrained (OSANT group, n = 21)
Number of subjects: 41
Study 29427059 — intervention group
Group type: EXPERIMENTAL
Intervention: ArthroPlanner software for surgical planning
Number of subjects: 58
Study 29427059 — intervention group
Group type: COMPARATOR
Intervention: Control group without planning
Number of subjects: 58
Study 29427059 — intervention group
Group type: EXPERIMENTAL
Intervention: ArthroPlanner software
Number of subjects: 58
Study 27320956 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy Defibrillator (CRT-D)
Number of subjects: 592
Study 24266733 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term cardiac rehabilitation (CR) program for 2 weeks
Number of subjects: 30
Study 24266733 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 30
Study 23300664 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical cerclage
Number of subjects: 112
Study 23300664 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone
Number of subjects: 112
Study 23300664 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study 20422817 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade perfusion
Number of subjects: 80
Study 20422817 — intervention group
Group type: COMPARATOR
Intervention: Retrograde perfusion
Number of subjects: 80
Study 20422817 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 80
Study 17396040 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-by-step rehabilitation programme (group A: 3-week rehabilitation plus 1-week sojourn at 4 and 8 months)
Number of subjects: 0
Study 17396040 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation programme (group B: 4-week stay, no further interventions)
Number of subjects: 0
Study 17396040 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-by-step rehabilitation programme (group A)
Number of subjects: 0
Study 15791520 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir (500 mg/m2 every 8 hours)
Number of subjects: 50
Study 15791520 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir (liquid formulation)
Number of subjects: 50
Study 15791520 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir
Number of subjects: 50
Study 15791520 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir
Number of subjects: 50
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs) with 50 microg ethinyl estradiol (EE)
Number of subjects: 626
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs) with 30-40 microg ethinyl estradiol (EE)
Number of subjects: 626
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OCs) with 20 microg ethinyl estradiol (EE)
Number of subjects: 626
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin-only pills
Number of subjects: 626
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives with second-generation progestins (levonorgestrel or norgestimate) and 20-30 microg EE
Number of subjects: 626
Study 11929641 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives with third-generation progestins (desogestrel or gestodene) and 20-30 microg EE
Number of subjects: 626
Study 11929641 — intervention group
Group type: COMPARATOR
Intervention: Comparison of third-generation to second-generation progestins
Number of subjects: 626
Study 10212716 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-Tenon's block with 2% lignocaine 1 ml containing 150 i.u. per ml of hyaluronidase with 2% plain lignocaine 2 ml and 0.5% plain bupivacaine 2 ml
Number of subjects: 120
Study 10212716 — intervention group
Group type: COMPARATOR
Intervention: Sub-Tenon's block with 2% plain lignocaine 3 ml with 0.5% plain bupivacaine 2 ml
Number of subjects: 120
Study 8540977 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard supplements (for groups 1 and 2)
Number of subjects: 16
Study 8540977 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased supplements (group 3)
Number of subjects: 16
Study 2215985 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1.5 mg/kg and Ketamine 1 mg/kg i.v.
Number of subjects: 40
Study 2215985 — intervention group
Group type: COMPARATOR
Intervention: Propofol 2.5 mg/kg and Fentanyl 1.5 micrograms/kg
Number of subjects: 40
Study 7000226 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of metronidazole intra-rectally 1 h preoperatively
Number of subjects: 104
Study 7000226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104
Study 31192722 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (n = 16)
Number of subjects: 31
Study 31192722 — intervention group
Group type: EXPERIMENTAL
Intervention: Story Telling (n = 15)
Number of subjects: 31
Study 28693614 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing access to treatment
Number of subjects: 35
Study 28693614 — intervention group
Group type: COMPARATOR
Intervention: Physical restraint
Number of subjects: 35
Study 28693614 — intervention group
Group type: COMPARATOR
Intervention: Lack of care options
Number of subjects: 35
Study 26093793 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus bevacizumab (DB)
Number of subjects: 90
Study 26093793 — intervention group
Group type: COMPARATOR
Intervention: S-1 plus bevacizumab (SB)
Number of subjects: 90
Study 24659022 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 0
Study 24659022 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 0
Study 22980289 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-balloon enteroscopy (SBE)
Number of subjects: 107
Study 22980289 — intervention group
Group type: COMPARATOR
Intervention: Double-balloon enteroscopy (DBE)
Number of subjects: 107
Study 19335905 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 2193
Study 17967712 — intervention group
Group type: COMPARATOR
Intervention: Oxidized regenerated cellulose/collagen biomaterial (Promogran)
Number of subjects: 51
Study 17967712 — intervention group
Group type: COMPARATOR
Intervention: Autologous growth factors delivered by Gravitational Platelet Separation System (GPS)
Number of subjects: 51
Study 17967712 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of oxidized regenerated cellulose/collagen biomaterial and autologous growth factors
Number of subjects: 51
Study 15595249 — intervention group
Group type: COMPARATOR
Intervention: Control group (102 patients without pituitary pathology)
Number of subjects: 202
Study 15595249 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with sellar lesions (100 patients)
Number of subjects: 202
Study 15595249 — intervention group
Group type: EXPERIMENTAL
Intervention: Operated patients (52 patients)
Number of subjects: 202
Study 15595249 — intervention group
Group type: EXPERIMENTAL
Intervention: BS positive patients (37 patients)
Number of subjects: 202
Study 15595249 — intervention group
Group type: EXPERIMENTAL
Intervention: RAH positive patients (28 patients)
Number of subjects: 202
Study 11259796 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with chronic fatigue syndrome (CFS)
Number of subjects: 0
Study 11259796 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 11541426 — intervention group
Group type: EXPERIMENTAL
Intervention: Inflated cuffs on the upper part of thighs and arms, performed 12 hours/day during bedrest
Number of subjects: 12
Study 11541426 — intervention group
Group type: COMPARATOR
Intervention: No countermeasures applied (control group)
Number of subjects: 12
Study 7835898 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger AD patients
Number of subjects: 0
Study 7835898 — intervention group
Group type: EXPERIMENTAL
Intervention: Older AD patients
Number of subjects: 0
Study 7835898 — intervention group
Group type: COMPARATOR
Intervention: Control brains (younger)
Number of subjects: 0
Study 7835898 — intervention group
Group type: COMPARATOR
Intervention: Control brains (older)
Number of subjects: 0
Study 3202098 — intervention group
Group type: EXPERIMENTAL
Intervention: Low copper diet for 11 weeks
Number of subjects: 0
Study 29426287 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative rectus sheath block (RSB) with 0.5% ropivacaine hydrochloride
Number of subjects: 61
Study 29426287 — intervention group
Group type: COMPARATOR
Intervention: Postoperative rectus sheath block (RSB) with saline
Number of subjects: 61
Study 29426287 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative rectus sheath block (RSB)
Number of subjects: 61
Study 26138736 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual sputum cytology/cytometry testing
Number of subjects: 1568
Study 26138736 — intervention group
Group type: COMPARATOR
Intervention: No screening
Number of subjects: 1568
Study 26147744 — intervention group
Group type: EXPERIMENTAL
Intervention: Probability-modifying plot (PMP)
Number of subjects: 874
Study 26147744 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural frequency tree (NFT)
Number of subjects: 874
Study 26147744 — intervention group
Group type: COMPARATOR
Intervention: Fagan's nomogram
Number of subjects: 874
Study 26147744 — intervention group
Group type: COMPARATOR
Intervention: Text summary of sensitivity and specificity
Number of subjects: 874
Study 26147744 — intervention group
Group type: EXPERIMENTAL
Intervention: PMP and NFT arms
Number of subjects: 874
Study 23391845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention program including education on medication adherence and hypertension, and provision of a home blood pressure monitoring device.
Number of subjects: 176
Study 23391845 — intervention group
Group type: COMPARATOR
Intervention: Usual pharmacy care (control group).
Number of subjects: 176
Study 23391845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention program (compared to control).
Number of subjects: 176
Study 20559696 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B education (experimental group)
Number of subjects: 218
Study 20559696 — intervention group
Group type: COMPARATOR
Intervention: Physical activity education (control group)
Number of subjects: 218
Study 18483061 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit tuck shops in intervention schools
Number of subjects: 1976
Study 18483061 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit tuck shops with school food policy restrictions
Number of subjects: 1976
Study 18483061 — intervention group
Group type: COMPARATOR
Intervention: No food allowed
Number of subjects: 1976
Study 18483061 — intervention group
Group type: COMPARATOR
Intervention: No restrictions on food
Number of subjects: 1976
Study 16475056 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval-trained athletes
Number of subjects: 101
Study 16475056 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control group
Number of subjects: 101
Study 15071244 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDR pacing
Number of subjects: 67
Study 15071244 — intervention group
Group type: EXPERIMENTAL
Intervention: VDD pacing
Number of subjects: 67
Study 15071244 — intervention group
Group type: EXPERIMENTAL
Intervention: VVIR pacing
Number of subjects: 67
Study 10611207 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG priming (10,000 IU) before immature oocyte retrieval
Number of subjects: 17
Study 10611207 — intervention group
Group type: COMPARATOR
Intervention: Non-HCG primed group
Number of subjects: 17
Study 9166129 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg oral DMSA
Number of subjects: 57
Study 1540053 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfer factor (1 mL at 3-month intervals after operation)
Number of subjects: 63
Study 1540053 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 63
Study 3546125 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of sterile gloves during suturing
Number of subjects: 242
Study 3546125 — intervention group
Group type: COMPARATOR
Intervention: No gloves during suturing
Number of subjects: 242
Study 29154132 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1-μg/kg over 10 min)
Number of subjects: 10
Study 29154132 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5-μg/kg over 10 min)
Number of subjects: 10
Study 29154132 — intervention group
Group type: COMPARATOR
Intervention: Zolpidem extended release
Number of subjects: 10
Study 27581674 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 108
Study 27581674 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 108
Study 25369444 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin reload
Number of subjects: 500
Study 25369444 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 22614920 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 μg once daily
Number of subjects: 0
Study 22614920 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 μg twice daily
Number of subjects: 0
Study 22614920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20205100 — intervention group
Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 52
Study 20205100 — intervention group
Group type: EXPERIMENTAL
Intervention: bisoprolol
Number of subjects: 52
Study 20205100 — intervention group
Group type: COMPARATOR
Intervention: amlodipine
Number of subjects: 52
Study 20205100 — intervention group
Group type: COMPARATOR
Intervention: indapamide
Number of subjects: 52
Study 18606020 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease Management Model
Number of subjects: 500
Study 18606020 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 500
Study 15827692 — intervention group
Group type: EXPERIMENTAL
Intervention: gel
Number of subjects: 120
Study 15827692 — intervention group
Group type: EXPERIMENTAL
Intervention: carmellose spray
Number of subjects: 120
Study 15827692 — intervention group
Group type: EXPERIMENTAL
Intervention: oil
Number of subjects: 120
Study 15827692 — intervention group
Group type: EXPERIMENTAL
Intervention: mucin spray
Number of subjects: 120
Study 11846848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype brush head B
Number of subjects: 78
Study 11846848 — intervention group
Group type: EXPERIMENTAL
Intervention: Prototype brush head A
Number of subjects: 78
Study 11846848 — intervention group
Group type: COMPARATOR
Intervention: Sensiflex 2000 (control)
Number of subjects: 78
Study 10636527 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of diuretics (<80 mg/day of furosemide)
Number of subjects: 111
Study 10636527 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of diuretics (>=80 mg/day of furosemide)
Number of subjects: 111
Study 10636527 — intervention group
Group type: COMPARATOR
Intervention: No treatment with diuretics prior to hospitalization
Number of subjects: 111
Study 8577814 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.125 mg
Number of subjects: 7
Study 8577814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 2200380 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program (integrated workbook, one-to-one counseling, adherence-enhancing strategies)
Number of subjects: 0
Study 2200380 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard asthma pamphlets)
Number of subjects: 0
Study 7302548 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulin substitution
Number of subjects: 82
Study 7302548 — intervention group
Group type: COMPARATOR
Intervention: No immunoglobulin substitution
Number of subjects: 82
Study 29215533 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of epiretinal membrane without removal of internal limiting membrane (ILM)
Number of subjects: 63
Study 29215533 — intervention group
Group type: COMPARATOR
Intervention: Removal of epiretinal membrane with removal of internal limiting membrane (ILM)
Number of subjects: 63
Study 29215533 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 63
Study 28203729 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal group (LG) - early postoperative oral fluid intake with apple juice (10 ml kg−1) offered if FLACC score ≥4 in PACU
Number of subjects: 231
Study 28203729 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - treated according to institutional opioid protocol, drinking allowed only upon return to the ward
Number of subjects: 231
Study 28203729 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal group (LG)
Number of subjects: 231
Study 28203729 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 231
Study 26439052 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (Group PR, n= 44)
Number of subjects: 81
Study 26439052 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (Group PK, n= 37)
Number of subjects: 81
Study 26439052 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (Group PR)
Number of subjects: 81
Study 26439052 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (Group PK)
Number of subjects: 81
Study 26439052 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 81
Study 23363689 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET)
Number of subjects: 22
Study 23363689 — intervention group
Group type: COMPARATOR
Intervention: Waiting-List (WL)
Number of subjects: 22
Study 22193485 — intervention group
Group type: EXPERIMENTAL
Intervention: Apex locator (AL)
Number of subjects: 46
Study 22193485 — intervention group
Group type: COMPARATOR
Intervention: Periapical radiograph (PA)
Number of subjects: 46
Study 19811503 — intervention group
Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg b.i.d.
Number of subjects: 410
Study 19811503 — intervention group
Group type: EXPERIMENTAL
Intervention: frovatriptan 2.5 mg q.d.
Number of subjects: 410
Study 19811503 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 410
Study 17074147 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/d fluoxetine
Number of subjects: 241